Oral Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Oral cancer (mouth cancer) is commonly referred to as head and neck cancer. According to WHO, oral cancer is a tumor in the buccal mucosa, the anterior two-thirds of the tongue, the lip, palate, vestibule, alveolus, the floor of the mouth, and gingivae. The most common symptoms of oral cancer include ulceration, induration and rupture, enlarged lesion, inflexible movement of the tongue, and difficulty in speaking and swallowing. Multifactorial etiology involved in the development and carcinogenesis of oral cancer, involving alcohol, tobacco, betel quid, high-risk human papillomavirus (HPV), poor nutrition, poor hygiene, immune system suppression, and bacterial infection. There are different stages to describe cancer: TNM staging system, oral cavity cancer, oropharynx cancer (unrelated to HPV), and HPV-related oropharyngeal cancer. Grading systems are also used for oral cancers, including grades GX, G1, G2, G3, and G4.
• The incidence of oral cancer in the USA is estimated to be 10.5 adults per 100,000. The cases are significantly higher in males than females.

Thelansis’s “Oral Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Oral Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Oral Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Oral Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Read more: Oral Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033